Portal de Periódicos da CAPES

Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging

2021; Society of Nuclear Medicine and Molecular Imaging; Volume: 63; Issue: 1 Linguagem: Inglês

10.2967/jnumed.121.263262

1535-5667

Hossein Jadvar, Jérémie Calais, Stefano Fanti, Felix Y. Feng, Kirsten L. Greene, James L. Gulley, Michael S. Hofman, Bridget F. Koontz, Daniel W. Lin, Michael J. Morris, Steve P. Rowe, Trevor J. Royce, Simpa S. Salami, Bital Savir-Baruch, Sandy Srinivas, Thomas A. Hope,

Radiopharmaceutical Chemistry and Applications

Prostate cancer is the most common cancer diagnosis in men in the United States and a leading cause of cancer-related morbidity and mortality ([ 1 ][1]). It can exist along a wide spectrum of aggressiveness and severity, from indolent, very-low-risk, localized prostate cancer to life-threatening,